Concepedia
Statistics
Publications
45
Citations
1.8K
H-Index
26
Active since
1983
Affiliations
PharmaMar (Spain)(Current)
The Netherlands Cancer Institute
Slotervaartziekenhuis
Utrecht University
Dr. Reddy's Laboratories (Switzerland)
Luis López Lázaro is an author at PharmaMar (Spain) specializing in pharmacology, medicine, and pharmacokinetics.
Publications per year
1983–2025
Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors
A. Taamma, J. L. Misset, M. Riofrio et al. · Journal of Clinical Oncology · 2001 · 160 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Erythema nodosum: Etiologic and predictive factors in a defined population
Carlos García‐Porrúa, Miguel Á. González‐Gay, Manuel Vázquez‐Caruncho et al. · Arthritis & Rheumatism · 2000 · 153 citations
Medicine, Dermatology, Internal Medicine +14
Phase I and Pharmacokinetic Study of Aplidine, a New Marine Cyclodepsipeptide in Patients With Advanced Malignancies
Sandrine Faivre, Stéphanie Chièze, Catherine Delbaldo et al. · Journal of Clinical Oncology · 2005 · 99 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +13
Phase I Clinical and Pharmacokinetic Study of Kahalalide F in Patients with Advanced Androgen Refractory Prostate Cancer
Jeany M. Rademaker-Lakhai, Simon Horenblas, W. Meinhardt et al. · Clinical Cancer Research · 2005 · 87 citations
Medicine, Pharmacokinetics, Pharmacology +16
A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignancies.
Miguel A. Villalona‐Calero, S. Gail Eckhardt, Geoffrey R. Weiss et al. · PubMed · 2002 · 82 citations
Medicine, Oncology, Pharmacology +15
1–5 of 45